|
FAM108A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.654370E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.237800E-01 |
| Normal-vs-Stage2 |
1.484170E-01 |
| Normal-vs-Stage3 |
7.147400E-01 |
| Normal-vs-Stage4 |
5.553000E-01 |
| Stage1-vs-Stage2 |
5.535800E-01 |
| Stage1-vs-Stage3 |
2.463200E-01 |
| Stage1-vs-Stage4 |
5.800600E-01 |
| Stage2-vs-Stage3 |
1.989650E-01 |
| Stage2-vs-Stage4 |
4.033400E-01 |
| Stage3-vs-Stage4 |
7.714600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.551400E-01 |
| Normal-vs-AfricanAmerican |
1.155820E-01 |
| Normal-vs-Asian |
2.007200E-01 |
| Caucasian-vs-AfricanAmerican |
3.897400E-01 |
| Caucasian-vs-Asian |
6.068400E-01 |
| AfricanAmerican-vs-Asian |
6.668400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.506500E-02 |
| Normal-vs-Female |
2.605600E-01 |
| Male-vs-Female |
3.417600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.423700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.927000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.420600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.105200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.806580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.045600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.608600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.669000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.590000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.817600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.01180000003465E-06 |
| Classical-VS-Follicular |
7.738100E-02 |
| Classical-VS-Other |
3.006800E-01 |
| Classical-VS-Normal |
2.484800E-01 |
| Tall-VS-Follicular |
4.81119999951041E-07 |
| Tall-VS-Other |
1.997020E-04 |
| Tall-VS-Normal |
3.376000E-03 |
| Follicular-VS-Other |
7.197400E-01 |
| Follicular-VS-Normal |
2.860100E-02 |
| Other-VS-Normal |
8.418300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.849540E-02 |
| Normal-vs-N1 |
4.147700E-02 |
| N0-vs-N1 |
8.591600E-01 |
|
|
